Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth

C G Steward1, R A Newbury-Ecob, R Hastings

  • 1Department of Paediatric Haematology, Oncology & BMT, Royal Hospital for Children, Upper Maudlin St, Bristol, UK. colin.steward@bristol.ac.uk

Prenatal Diagnosis
|September 3, 2010
PubMed

Insights

Barth Syndrome (BTHS) significantly impacts fetal and perinatal health, particularly in males, leading to increased stillbirths and neonatal deaths. Early diagnosis is crucial for managing this X-linked disorder.

Area of Science:

  • Genetics
  • Pediatrics
  • Cardiology

Background:

  • Barth Syndrome (BTHS) is an X-linked disorder affecting multiple systems, typically diagnosed in infancy.
  • Key features include cardiac issues (dilated cardiomyopathy, endocardial fibroelastosis, left ventricular non-compaction), myopathy, growth issues, neutropenia, and metabolic abnormalities.

Purpose of the Study:

  • To investigate the impact of Barth Syndrome on fetal and perinatal health.
  • To analyze a large cohort of family groups from a defined region.

Main Methods:

  • Retrospective case note review of 19 families linked to the Barth Syndrome Service at Bristol Royal Hospital for Children.
  • Genetic and biochemical confirmation of BTHS in affected individuals.

Main Results:

  • Six kindreds (32%) with confirmed BTHS showed a broader phenotype, including male fetal loss and stillbirth.
  • Nine males were stillborn, and 14 died neonatally or in infancy; no female losses were reported.
  • Five males presented with fetal onset of cardiac conditions (DCM, hydrops, EFE, LVNC).

Conclusions:

  • Barth Syndrome should be considered in cases of unexplained male hydrops, fetal loss, and severe neonatal conditions.
  • The findings highlight the critical role of BTHS in fetal and perinatal mortality and morbidity.
  • Early consideration of BTHS is vital for conditions like hypoglycemia, lactic acidosis, and mitochondrial disease in neonates.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...